PREDICTA MED

Tel Aviv, Israel Founded: 2019 • Age: 7 yrs
Provides AI based selection and treatment for autoimmune diseases
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About PREDICTA MED

PREDICTA MED is a company based in Tel Aviv (Israel) founded in 2019 by Shlomit Steinberg-Koch. PREDICTA MED offers products and services including Predicta Med Platform. PREDICTA MED operates in a competitive market with competitors including PHRASE Health, Pacific Knowledge Systems, Medical Information Solutions, Klinik Healthcare Solutions and MyUroflow, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Shlomit Steinberg-Koch
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Predicta-Med Ltd
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PREDICTA MED

PREDICTA MED offers a comprehensive portfolio of products and services, including Predicta Med Platform.

Product name locked
Category locked
Primary

Platform analyzes medical data for early detection of autoimmune diseases.

Funding Insights of PREDICTA MED

Investors in PREDICTA MED

PREDICTA MED has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include CerraCap Ventures and Moshe Shoham.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Early-stage tech companies in Asia and the US are funded.
Locked Locked Locked

Moshe Shoham

Indian angel investor, tech enthusiast, focused on early-stage startups
Locked Locked Locked
Premium access

Investor details for PREDICTA MED

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PREDICTA MED

Investments
Premium access

Investment portfolio details for PREDICTA MED

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PREDICTA MED

Premium access

Detailed financials for PREDICTA MED

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Predicta Med Comparisons

PREDICTA MED Primary company
Description
Provides AI based selection and treatment for autoimmune dis...
Location
Tel Aviv, Israel
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for PREDICTA MED

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PREDICTA MED

PREDICTA MED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PHRASE Health, Pacific Knowledge Systems, Medical Information Solutions, Klinik Healthcare Solutions and MyUroflow, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Decision support tool for healthcare providers at the point of care
Locked Locked Locked
Clinical decision support, monitoring, and lab audit software is provided.
Locked Locked Locked
Medical information handbook for doctors
Locked Locked Locked
AI-based decision support platform for healthcare professionals
Locked Locked Locked
Remote monitoring platform for urological health and patient data tracking.
Premium access

Detailed competitors of PREDICTA MED

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Predicta Med

Premium access

Complete news archive for PREDICTA MED

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PREDICTA MED

PREDICTA MED was founded in 2019 and raised its 1st funding round 1 year after it was founded.

PREDICTA MED is headquartered in Tel Aviv, Israel.

Shlomit Steinberg-Koch is the current CEO of PREDICTA MED. They have also founded this company.

PREDICTA MED provides ai based selection and treatment for autoimmune diseases through healthtech, healthcare it, provider, clinical operations, decision support, diagnosis, differential diagnosis, health records based, and disease agnostic. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

PREDICTA MED's top competitors include PHRASE Health, Medical Information Solutions and Klinik Healthcare Solutions.

PREDICTA MED offers Predicta Med Platform.

PREDICTA MED has 2 investors. Key investors include CerraCap Ventures, and Moshe Shoham.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available